Notice ID
8aed906ac90649f1a43c272e8a1aedc5
The Luminex xMAP technology that is utilized in Luminex assays to precisely measure multiple analytes simultaneously in one sample The colorcoded beadbased assays use internally dyed beads that correspond to a distinct spectral signature from which beadbound antibodies specific to target analytes can be detected and quantified Additionally these assays undergo multiple quality control steps to ensure longterm reproducibility and consistency and requires only a small sample volume These assays have been optimized and validated for optimal performance The antibodies used are specific to each target and have been confirmed to have little crossover which limits variability between assays The specificity and reproducibility of this assay is not offered using other products
-
Department/Ind.Agency
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
-
Subtier
CENTERS FOR DISEASE CONTROL AND PREVENTION
-
Office
CDC OFFICE OF ACQUISITION SERVICES